Market Access/ News/ News Pharming files rare disease drug leniolisib in Europe Phil Taylor activated PI3K delta syndrome, leniolisib, Pharming, rare disease 0 Comment Pharming has submitted its oral phosphoinositide 3-kinase delta (PI3Kδ) inhibitor leniolisib for approval in the EU as a Share X Pharming files rare disease drug leniolisib in Europe https://pharmaphorum.com/news/pharming-files-rare-disease-drug-leniolisib-in-europe/
News/ News/ R&D Pharming preps filing for rare disease drug leniolisib after trial win Phil Taylor activated PI3K delta syndrome, leniolisib, Novartis, Pharming, rare disease 0 Comment Pharming has taken a step closer to getting a second product to market, after its rare disease therapy Share X Pharming preps filing for rare disease drug leniolisib after trial win https://pharmaphorum.com/news/pharming-preps-filing-for-rare-disease-drug-leniolisib-after-trial-win/
activated PI3K delta syndrome, leniolisib, Pharming, rare disease
0 Comment
